USEA (USEA) Stock Price & Analysis
USEA (USEA) fell 1.54% to USD 2.55 as of July 26, 2026 at 16:23 UTC, according to Nexqual real-time market data.
USEA last closed at USD 2.59; the session ranged USD 2.51–2.61 on volume of 10,482 shares. Market capitalization is $24.32M, with a 52-week range of USD 1.42–2.82 (NCM). Source: Nexqual, July 26, 2026 at 16:23 UTC.
Key Statistics (as of July 26, 2026 at 16:23 UTC)
| Price | USD 2.55 |
|---|---|
| Change | ▼ 1.54% (down) |
| Previous Close | USD 2.59 |
| Open | USD 2.61 |
| Day Range | USD 2.51 – 2.61 |
| 52-Week Range | USD 1.42 – 2.82 |
| Volume | 10,482 shares |
| Market Cap | $24.32M |
| Exchange | NCM |
Technical Analysis (USEA)
Nexqual's technical model rates USEA "SELL" based on 1 bullish and 3 bearish signals across 125 daily candles, as of July 26, 2026 at 16:23 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 47.94 (neutral) |
| vs SMA50 | Below (USD 2.56) |
| MACD | 0 (negative) |
Analyst Ratings (USEA)
Wall Street analysts rate USEA "None" based on 1 analysts, with a mean price target of USD 4 (range USD 4–4), per Nexqual as of July 26, 2026 at 16:23 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 1 |
| Mean Target | USD 4 |
| High Target | USD 4 |
| Low Target | USD 4 |
| Buy / Hold / Sell | 1 / 0 / 0 |
Earnings (USEA)
| Next Earnings Date | 2026-08-05 |
|---|---|
| Revenue Estimate | $9.80M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD -0.01 vs est -0.12 ▲ beat |
| 2025-12-31 | USD -0.17 vs est -0.04 ▼ miss |
| 2025-09-30 | USD 0.12 vs est -0.15 ▲ beat |
| 2025-06-30 | USD 0.02 vs est -0.14 ▲ beat |
Source: Nexqual, July 26, 2026 at 16:23 UTC.
Financials & Fundamentals (USEA)
| Total Revenue | $37.98M |
|---|---|
| Revenue Growth (YoY) | +2.50% |
| Gross Margin | +42.86% |
| Operating Margin | +12.16% |
| Profit Margin | -4.85% |
| ROE | -3.36% |
| Debt / Equity | 161.51 |
| Total Cash | $10.13M |
| Total Debt | $89.72M |
Source: Nexqual, July 26, 2026 at 16:23 UTC.
Financial Health Score (USEA)
Nexqual rates USEA's overall financial health "Weak" across five dimensions, as of July 26, 2026 at 16:23 UTC.
| Growth | Critical — Revenue -17% YoY (annual), sharp decline |
|---|---|
| Profitability | Weak — Small revenue base — building scale |
| Balance Sheet | Weak — $10M cash vs $90M debt |
| Cash Flow | Mixed — No data |
| Efficiency | Critical — ROE -3%, ROA 1.3% |
Ownership (USEA)
| Insider Ownership | +24.64% |
|---|---|
| Institutional Ownership | +6.68% |
| Shares Outstanding | 9.54M |
| Float | 6.73M |
| Short % of Float | +12.66% |
Source: Nexqual, July 26, 2026 at 16:23 UTC.
Leadership (USEA)
USEA is led by Stamatios Tsantanis (age 53), Chairman & CEO, per Nexqual as of July 26, 2026 at 16:23 UTC.
| Chairman & CEO | Stamatios Tsantanis (age 53) |
|---|---|
| CFO & Director | Stavros Gyftakis (age 46) |
Major Backers & Investors (USEA)
Notable institutional backers of USEA include Renaissance Technologies, UBS Group AG, Angeles Wealth Management, LLC , according to Nexqual as of July 26, 2026 at 16:23 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Renaissance Technologies | 2.44% |
| UBS Group AG | 0.84% |
| Angeles Wealth Management, LLC | 0.81% |
| Acadian Asset Management. LLC | 0.58% |
| Focus Partners Wealth | 0.33% |
| Centiva Capital, LP | 0.32% |
| Jane Street Group, LLC | 0.3% |
| NewEdge Advisors, LLC | 0.28% |
Source: Nexqual, July 26, 2026 at 16:23 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ILAG | Intelligent Living Application | USD 3.45 | ▼ 0.23% |
| PSHG | Performance Shipping Inc. | USD 1.78 | ▲ 0.56% |
| CMRA | Comera Life Sciences Holdings, | USD 0 | ▲ 0% |
| QNRX | Quoin Pharmaceuticals, Ltd. | USD 4.28 | ▼ 2.17% |
| REVB | Revelation Biosciences, Inc. | USD 1.06 | ▼ 7.83% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 26, 2026 at 16:23 UTC. This page is informational and not investment advice.